Fig. 1From: LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axisLncRNA WDFY3-AS2 expression was increased in cisplatin-resistant OC. A qRT-PCR expression analysis of LncRNA WDFY3-AS2 in OC cell (A2780-DDP cells and A2780 cells). B Detection of cell ability of OC cells with (0, 5, 10, 15, 20, 25, 30 μM) cisplatin treatment by CCK-8 assay. ***P < 0.001Back to article page